Thromboelastography to Assess Hemostatic Changes in Laboring Patients Undergoing Non-elective (Intrapartum) Cesarean Delivery

The purpose of the study is to assess the coagulation changes that occur in laboring patients undergoing non-elective (intrapartum)Cesarean delivery using thromboelastography (TEG). We will compare coagulation data to assess potential coagulation changes associated with hemoglobin changes before and after surgery, and related to estimated blood loss.

Stanford is not currently accepting new patients for this trial. You may want to check to see if other locations are recruiting.


Phase: N/A


Ages Eligible For Study:

18 Years - 40 Years

Inclusion Criteria

- Obstetric in-patients - Laboring patients with Epidurals for Labor Analgesia going for non-elective Cesarean - Patients of all ethnic backgrounds will be included - Singleton pregnancy - ASA 1 or 2

External Links

Explore related trials

Contact information

Primary Contact:

Alexander J Butwick, MBBS, FRCA 6507368513

Stanford University School of Medicine 300 Pasteur Drive Stanford, CA 94305

Stanford Medicine Resources:

Footer Links: